SRTD Biotech
Developer of selectively expressed RNA (seRNA) precision therapeutics.
SRTD Biotech is a biotech & life sciences company based in Jülich, DE, founded in 2019. It has raised $35.26 million in disclosed funding. Its latest round was a Seed of €31.5 million in November 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $35.3M across 1 round. Computed only from sourced rounds.
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| €31.5M | Seed | Mérieux Equity Partners, NRW.BANK, Boehringer Ingelheim Venture Fund | Lilly Ventures +2 | Biotech & Life Sciences | 3 |
Nov 10 · Seed
SRTD Biotech€31.5MLed by Mérieux Equity Partners, NRW.BANK, Boehringer Ingelheim Venture Fund · with Lilly Ventures, +2
Investors
Questions and answers
What does SRTD Biotech do?
Developer of selectively expressed RNA (seRNA) precision therapeutics.
How much has SRTD Biotech raised?
SRTD Biotech has raised $35.26 million in disclosed funding across 1 round tracked by OSH.
Who has invested in SRTD Biotech?
Investors in SRTD Biotech include Mérieux Equity Partners, NRW.BANK, Boehringer Ingelheim Venture Fund, Lilly Ventures, HTGF and 1 more.
When and where was SRTD Biotech founded?
SRTD Biotech was founded in 2019 and is based in Jülich, DE.
Timeline
Founded
Sources
- 1.Why Lilly and Boehringer backed a German startup’s mRNA ‘on-off switch’ in a €31.5M seed — TFN — techfundingnews.com
- 2.mRNA therapy company SRTD Biotech has complet... — chaincatcher.com
- 3.SRTD Biotech Raises €31.5M in Seed Funding — finsmes.com